ArticleJournal of experimental & clinical cancer research : CR2022

ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.

Zijie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.